Navigation Links
Genes Might Be Key to Parkinson's Spread
Date:5/15/2012

TUESDAY, May 15 (HealthDay News) -- Researchers have identified gene variants that speed the progression of Parkinson's disease, and they say their findings could help identify patients who would benefit most from early treatment.

The researchers, from the University of California-Los Angeles, say their findings also may help efforts to develop new therapies.

Parkinson's disease is a progressive movement disorder marked by tremor, slowness and rigidity.

The researchers followed 233 patients for an average of about five years after they were diagnosed with the disorder. They focused on two variants of the SNCA gene, which is known to play a role in a person's risk for Parkinson's disease.

The study found that patients with the "Rep1 263bp" variant of the SNCA gene had a fourfold faster decline in their ability to move. The decline was even more rapid in patients with both the "Rep1 263bp" and "rs356165" variants of the gene.

"This is a relatively small study ... but the effects we're seeing are actually quite large," primary investigator Dr. Beate Ritz, vice chairwoman of the department of epidemiology at UCLA's School of Public Health, said in a university news release.

The study was published today in the journal PLoS One.

Doctors currently can't predict how rapidly Parkinson's disease patients will reach the point where they require a wheelchair or other mobility aids.

"But if our results are confirmed, these gene variants can now identify patients who are likely to have faster progression," study co-author Dr. Jeff Bronstein, professor of neurology at UCLA's School of Medicine, said in the news release.

The accelerated rate of disease progression in patients with these two gene variants means they may be able to provide researchers with faster results on tests of new drugs for Parkinson's, the researchers said.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about Parkinson's disease.

-- Robert Preidt

SOURCE: University of California-Los Angeles, news release, May 11, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
2. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
3. Genes, environment, or chance?
4. UCLA study reveals how genes interact with their environment to cause disease
5. Long-Distance Runners May Have Endurance in Their Genes
6. Genes Behind Tooth Development Discovered
7. Smoking significantly increases risk of aneurysm in people with certain genes
8. Increasing neurogenesis might prevent drug addiction and relapse
9. Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day
10. Cluster of Genes Tied to Alcoholism
11. Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genes Might Be Key to Parkinson's Spread
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: